MedPath

Health Canada Approvals

Health Canada approved pharmaceutical products and drug approvals in Canada

Health Canada
Canada
282 Approvals
Showing 1 to 20 of 282 approvalsPage 1 of 15

JAMPLYTE

Approved: Jun 17, 2025

M-RIZATRIPTAN ODT

Approved: Jun 10, 2025
mantra pharma inc

M-RIZATRIPTAN ODT

Approved: Jun 10, 2025
mantra pharma inc

PRECISE PAIN RELIEF CREAM

Approved: Jun 9, 2025
mcneil consumer healthcare division of johnson & johnson inc

PRECISE COOLING PAIN RELIEF CREAM

Approved: Jun 9, 2025
mcneil consumer healthcare division of johnson & johnson inc

MOMETASONE

Approved: Jun 6, 2025
sivem pharmaceuticals ulc

CYCLOPHOSPHAMIDE FOR INJECTION USP

Approved: Jun 6, 2025
andone pharmaceutical inc

CYCLOPHOSPHAMIDE FOR INJECTION USP

Approved: Jun 6, 2025
andone pharmaceutical inc

NB-RIVAROXABAN

Approved: Jun 5, 2025
nb pharma inc.

NB-PREGABALIN

Approved: Jun 5, 2025
nb pharma inc.

NB-PREGABALIN

Approved: Jun 5, 2025
nb pharma inc.

NB-PREGABALIN

Approved: Jun 5, 2025
nb pharma inc.

NB-PREGABALIN

Approved: Jun 5, 2025
nb pharma inc.

NB-APIXABAN

Approved: Jun 5, 2025
nb pharma inc.

NB-ROSUVASTATIN

Approved: Jun 5, 2025
nb pharma inc.

NB-PREGABALIN

Approved: Jun 5, 2025
nb pharma inc.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.